[
    {
        "molecule_name": "nanobodies",
        "protein_target_name": "2PT-NBD1 and F508del-2PT-NBD1",
        "binding_metric": "EC50",
        "value": "1 to 50",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nDose response curves indicated a highly potent binding to 2PT-NBD1 and F508del-2PT-NBD1 (EC50 in the 1 nM to 50 nM range) for all nanobodies, except nanobody G3a, which displayed a weaker binding potency (Fig. la,e).\nIn each case the titrations were consistent with a 1:1 bimolecular association between nanobodies and monomeric 2PT-NBD1 with KΏ values of 54 ± 10, 25 ± 10, 37.9 ± 7, and 39 ± 2 nM with nanobodies T2a, T27, T4, and T8 respectively.\nNanobody G3a bound 2PT-NBD1 with a lower affinity (1.1 mM ± 0.1 pM) which is consistent with our determination of apparent affinity by ELISA (Fig. la,e)."
    },
    {
        "molecule_name": "nanobody T2a",
        "protein_target_name": "2PT-NBD1",
        "binding_metric": "Kd",
        "value": "54 ± 10",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nDose response curves indicated a highly potent binding to 2PT-NBD1 and F508del-2PT-NBD1 (EC50 in the 1 nM to 50 nM range) for all nanobodies, except nanobody G3a, which displayed a weaker binding potency (Fig. la,e).\nIn each case the titrations were consistent with a 1:1 bimolecular association between nanobodies and monomeric 2PT-NBD1 with KΏ values of 54 ± 10, 25 ± 10, 37.9 ± 7, and 39 ± 2 nM with nanobodies T2a, T27, T4, and T8 respectively.\nNanobody G3a bound 2PT-NBD1 with a lower affinity (1.1 mM ± 0.1 pM) which is consistent with our determination of apparent affinity by ELISA (Fig. la,e)."
    },
    {
        "molecule_name": "nanobody T27",
        "protein_target_name": "2PT-NBD1",
        "binding_metric": "Kd",
        "value": "25 ± 10",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nDose response curves indicated a highly potent binding to 2PT-NBD1 and F508del-2PT-NBD1 (EC50 in the 1 nM to 50 nM range) for all nanobodies, except nanobody G3a, which displayed a weaker binding potency (Fig. la,e).\nIn each case the titrations were consistent with a 1:1 bimolecular association between nanobodies and monomeric 2PT-NBD1 with KΏ values of 54 ± 10, 25 ± 10, 37.9 ± 7, and 39 ± 2 nM with nanobodies T2a, T27, T4, and T8 respectively.\nNanobody G3a bound 2PT-NBD1 with a lower affinity (1.1 mM ± 0.1 pM) which is consistent with our determination of apparent affinity by ELISA (Fig. la,e)."
    },
    {
        "molecule_name": "nanobody T4",
        "protein_target_name": "2PT-NBD1",
        "binding_metric": "Kd",
        "value": "37.9 ± 7",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nDose response curves indicated a highly potent binding to 2PT-NBD1 and F508del-2PT-NBD1 (EC50 in the 1 nM to 50 nM range) for all nanobodies, except nanobody G3a, which displayed a weaker binding potency (Fig. la,e).\nIn each case the titrations were consistent with a 1:1 bimolecular association between nanobodies and monomeric 2PT-NBD1 with KΏ values of 54 ± 10, 25 ± 10, 37.9 ± 7, and 39 ± 2 nM with nanobodies T2a, T27, T4, and T8 respectively.\nNanobody G3a bound 2PT-NBD1 with a lower affinity (1.1 mM ± 0.1 pM) which is consistent with our determination of apparent affinity by ELISA (Fig. la,e)."
    },
    {
        "molecule_name": "nanobody T8",
        "protein_target_name": "2PT-NBD1",
        "binding_metric": "Kd",
        "value": "39 ± 2",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nDose response curves indicated a highly potent binding to 2PT-NBD1 and F508del-2PT-NBD1 (EC50 in the 1 nM to 50 nM range) for all nanobodies, except nanobody G3a, which displayed a weaker binding potency (Fig. la,e).\nIn each case the titrations were consistent with a 1:1 bimolecular association between nanobodies and monomeric 2PT-NBD1 with KΏ values of 54 ± 10, 25 ± 10, 37.9 ± 7, and 39 ± 2 nM with nanobodies T2a, T27, T4, and T8 respectively.\nNanobody G3a bound 2PT-NBD1 with a lower affinity (1.1 mM ± 0.1 pM) which is consistent with our determination of apparent affinity by ELISA (Fig. la,e)."
    },
    {
        "molecule_name": "nanobody G3a",
        "protein_target_name": "2PT-NBD1",
        "binding_metric": "Kd",
        "value": "1.1",
        "unit": "mM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nDose response curves indicated a highly potent binding to 2PT-NBD1 and F508del-2PT-NBD1 (EC50 in the 1 nM to 50 nM range) for all nanobodies, except nanobody G3a, which displayed a weaker binding potency (Fig. la,e).\nIn each case the titrations were consistent with a 1:1 bimolecular association between nanobodies and monomeric 2PT-NBD1 with KΏ values of 54 ± 10, 25 ± 10, 37.9 ± 7, and 39 ± 2 nM with nanobodies T2a, T27, T4, and T8 respectively.\nNanobody G3a bound 2PT-NBD1 with a lower affinity (1.1 mM ± 0.1 pM) which is consistent with our determination of apparent affinity by ELISA (Fig. la,e)."
    }
]